Intrinsic Value of S&P & Nasdaq Contact Us

Rezolute, Inc. RZLT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.86
+120.7%

Rezolute, Inc. (RZLT) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 12 recommend buying, 0 recommend holding, and 0 recommend selling.

The analyst consensus price target for RZLT is $7.86, representing a +120.7% upside from the current price of $3.561. Price targets range from a low of $2.00 to a high of $20.00.

Analyst Consensus — RZLT

Buy
Strong Buy
0
Buy
12
Hold
0
Sell
0
Strong Sell
0
12 analysts
Price Targets
Consensus$7.86
High$20.00
Low$2.00
Median$5.00
Last Month Avg-
Last Quarter Avg$2.00
Last Year Avg$8.44
All-Time Count13
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message